###### Key messages

-   Surgery in CRC patients with COPD is more frequently associated with complications leading to ICU admission/treatments, and reoperations, compared to CRC patients without COPD.

-   COPD is clearly associated with increased mortality especially in patients with colon cancer.

Introduction {#s1}
============

Colorectal cancer (CRC) is a common disease, with a first-time diagnosis occurring at a median age of approximately 70 years.[@R1] [@R2] Surgical resection of the tumour has the potential to cure early-stage CRC, either alone or combined with chemotherapy and/or radiation.[@R3] Overall, 30-day mortality after CRC resection has been estimated to be approximately 10%,[@R4] with higher rates among elderly patients compared to younger patients.[@R5]

Many patients with CRC have concurrent chronic diseases, including chronic obstructive pulmonary disease (COPD). Evidence suggests that COPD is associated with substantially increased mortality after various types of surgery.[@R4] [@R6] Much of this evidence originates from studies of patients undergoing surgery for perforated peptic ulcers, cardiac procedures, hip fractures and abdominal aortic aneurysm repair.[@R6] [@R11] The studies have mainly included COPD as a covariate in analyses for other purposes like hospital variation in mortality[@R4] have combined several types of cancer or lung diseases[@R9] [@R12] or focused only on men.[@R10] However, evidence of an association between COPD and postoperative outcome after CRC surgery is limited.[@R4] [@R9] [@R10] [@R13]

A primary reason for increased postoperative mortality among patients with COPD may be respiratory failure, leading to more frequent and longer intensive care unit (ICU) admissions.[@R7] [@R11] In addition, patients with a high comorbidity burden have in general been found to be at increased risk of surgical complications, leading in turn to a need for reoperation,[@R14] but none of the former studies have examined the risk of postoperative admission to the ICU among patients undergoing CRC surgery.

We conducted a nationwide population-based cohort study to investigate the impact of COPD on ICU admissions, ICU treatments (mechanical ventilation, non-invasive ventilation (NIV), dialysis and treatment with inotropes/vasopressors), occurrence of reoperation and 30-day mortality following CRC surgery.

Methods {#s2}
=======

Settings {#s2a}
--------

This cohort study was conducted in Denmark, a country with 5.5 million inhabitants.

All Danish citizens have equal access to tax-funded medical care, and all CRC surgery is performed in public hospitals.

Since 1968, everyone living in Denmark has been assigned a personal civil registration number (CPR number) by the Danish Civil Registration System (CRS).[@R15] The CRS is updated daily and contains information on gender, date of birth and vital status. We used the CPR number to link registries at the individual level.

Patients {#s2b}
--------

We used the Danish Cancer Registry (DCR) to identify all patients with CRC diagnosed in the period from 1 January 2005 until 31 December 2011. This period was chosen because ICU admissions have been recorded since 2005. The DCR, established in 1943, covers all incident cancer cases in Denmark through notification from hospital departments, specialists and autopsy reports.[@R16] DCR data include CPR number, month and year of cancer diagnosis and tumour spread at the time of diagnosis. We classified CRC stages as localised (Dukes' A and B), regional (Dukes' C), metastasised (Dukes' D) or unknown (see e-appendix 1).

We linked the patients with CRC to the Danish National Registry of Patients (DNRP), in order to identify date of CRC surgery. The DNRP, a nationwide registry established in 1977, contains records on 99.4% of all discharges from Danish hospitals.[@R17] Emergency room and outpatient clinic visits have been included since 1995 and ICU admissions, including information on use of mechanical ventilation and other ICU treatments, since 2005.

The DNRP includes data on CPR number, hospital, department, discharge diagnoses and surgical and diagnostic procedures. Diagnoses were coded according to the *International Classification of Diseases*, 8th revision (ICD-8) until 1993 and 10th revision (ICD-10) thereafter. Our study cohort consisted of patients who underwent CRC surgery (see e-appendix 1 for surgical procedure codes). We categorised CRC surgery as open surgery, laparoscopic resection or other surgery; in addition, we investigated colon and rectal cancer surgery separately. We also categorised type of admission as acute or elective because acute surgery has been shown to be associated with increased mortality.[@R4] Furthermore, we divided hospitals according to volume: low volume (less than 500 CRC surgeries in the study period) and high volume (more than 500 CRC surgeries in the study period).

### Patients with COPD {#s2b1}

Within the cohort of CRC surgery patients, we searched the DNRP for any inpatient COPD diagnosis since 1977. In addition, we identified and included patients diagnosed with COPD in outpatient specialist clinics and emergency rooms since 1995 (ICD codes are provided in e-appendix 1).

Main outcome measures {#s2c}
---------------------

### Admission to the ICU, ICU treatments, reoperation and death {#s2c1}

We obtained data from the DNRP on ICU admissions,[@R18] use of mechanical ventilation, treatment with NIV, dialysis, inotropic treatment and reoperations within 30 days following surgery as a marker of surgical complications.[@R19] To avoid including prophylactic ICU admissions as a marker of surgical complications, we only included ICU admission occurring at least 1 day after surgery. In addition, we divided the reason for reoperation according to the procedure code into five groups: infection, bleeding, wound rupture, anastomosis leakage and other reasons (procedure codes are provided in e-appendix 1). To investigate 30-day mortality, CRS data were used to follow patients from date of CRC surgery until death, emigration, 30 days postoperatively or the end of the study period, whichever came first.

### Comorbidities {#s2c2}

We used Charlson Comorbidity Index (CCI) scores to assess comorbidity levels in the study cohort.[@R20] The CCI score is computed as the sum of points (between 1 and 6) assigned to each of the 19 diseases included in the index (see e-appendix 1).[@R20] Information on comorbid diseases was obtained from the DNRP, including all inpatient and outpatient diagnoses within 5 years prior to date of CRC surgery. Patients were classified into three groups according to their CCI score: 0 points ('low comorbidity level'); 1--2 points ('moderate comorbidity level'); and 3 or more points ('severe comorbidity level'). We excluded COPD and CRC from the CCI as they represent the exposure and the patient population under study. In addition to the CCI score, our analyses included data on alcohol-related diseases and obesity from the DNRP (see e-appendix 1).

### Statistical analyses {#s2c3}

We calculated frequencies of covariates (including categories of demographic characteristics, CCI scores, types of admission (elective or acute), types of surgery, hospital volume and cancer stage) according to the presence or absence of COPD. We computed the rates of patients with CRC who were admitted to the ICU 1--30 days after surgery, and received mechanical ventilation, NIV, dialysis, inotropes/vasopressors or underwent reoperation within 30 days after surgery. In a sensitivity analysis, we also computed the rate of ICU admission 0--30 days after surgery. We used Jeffrey\'s method to compute 95% CIs for the rates.[@R21] We estimated and plotted 30-day mortality according to presence/or absence of COPD for all CRC surgery patients and for those with colon and rectal cancer separately, using the Kaplan-Meier method. We used a Cox regression model to compute HRs with 95% CIs as a measure for the relative risk of death, in order to compare mortality rates among patients with CRC with and without COPD. We adjusted for the following potential confounders: age, gender, type of admission (elective/acute), cancer stage, hospital volume, alcohol-related diseases (as a measure for heavy alcohol consumption), obesity and CCI score. Patients with CRC without COPD constituted the comparison group. In order to examine any potential differences in the influence of COPD within particular subgroups, we repeated the regression analyses stratified by age, gender, presence/absence of a comorbid condition according to the Charlson comorbidity score, admission type (elective/acute), surgery type, hospital volume and CRC stage.

All statistical analyses were performed using STATA software (V.10.0 StataCorp LP, College Station, Texas, USA).

All data were obtained from Danish registries, which are generally available to researchers, and their use does not require ethical approval or informed consent.

Results {#s3}
=======

Descriptive data {#s3a}
----------------

We identified 18 302 CRC surgery patients, of whom 1449 (7.9%) had a COPD diagnosis. The proportion of patients with COPD was slightly higher among patients with colon cancer (8.3% of 12 053 patients with colon cancer) compared to patients with rectal cancer (7.1% of 6249 patients with rectal cancer).

Patients with CRC with COPD were older and had a higher comorbidity level than patients with CRC without COPD. Gender, admission type (elective/acute), surgery type and CRC stage at time of diagnosis were very similar in patients with and without COPD ([table 1](#BMJRESP2014000036TB1){ref-type="table"}).

###### 

Characteristics of patients undergoing colon and rectal cancer surgery by presence/absence of a previous diagnosis of COPD, Denmark, 2005--2011

                                                       Colon cancer   Rectal cancer                                       
  ---------------------------------------------------- -------------- --------------- -------- ------ ----- ------ ------ ------
  Total                                                1006           100             11 047   100    443   100    5806   100
  Age group (years)                                                                                                       
   0--59                                               40             4.0             1784     16.2   32    7.2    1280   22.0
   60--69                                              178            17.7            3090     28.0   92    20.8   1934   33.3
   70--79                                              406            40.3            3504     31.7   202   45.6   1654   28.5
   80+                                                 382            38.0            2669     24.1   117   26.4   938    16.2
  Gender                                                                                                                  
   Female                                              512            50.9            5604     50.7   173   39.1   2232   38.4
   Male                                                494            49.1            5443     49.3   270   60.9   3574   61.6
  Charlson score                                                                                                          
   0                                                   572            56.9            8340     75.5   272   61.4   4625   79.7
   1--2                                                335            33.3            2141     19.4   125   28.2   867    14.9
   \>3                                                 99             9.8             566      5.1    46    10.4   314    5.4
  Charlson score                                                                                                          
   Myocardial infarction                               55             5.5             265      2.4    28    6.3    120    2.1
   Congestive heart failure                            131            13.0            346      3.1    43    9.7    133    2.3
   Peripheral vascular disease                         66             6.6             358      3.2    33    7.5    134    2.3
   Cerebrovascular disease                             104            10.3            701      6.4    43    9.7    288    5.0
   Dementia                                            13             1.3             96       0.9    6     1.4    51     0.9
   Connective tissue disease                           42             4.2             225      2.0    13    2.9    68     1.2
   Ulcer disease                                       46             4.6             351      3.2    15    3.4    55     1.0
   Mild liver disease                                  9              0.9             51       0.5    6     1.3    28     0.5
   Diabetes I and II                                   122            12.1            686      6.2    37    8.3    298    5.1
   Hemiplegia                                          3              0.3             10       0.1    1     0.2    2      0.1
   Moderate/severe renal disease                       35             3.5             135      1.2    7     1.6    50     0.9
   Diabetes with complication                          51             5.1             304      2.8    18    4.1    131    2.3
   Any tumour (except colon and rectal)                15             1.5             93       0.8    3     0.7    45     0.8
   Leukaemia                                           0              0.0             5        0.1    1     0.2    2      0.03
   Lymphoma                                            0              0.0             5        0.1    0     0.0    1      0.02
   Moderate/severe liver disease                       3              0.3             11       0.1    1     0.2    7      0.1
   Metastatic solid tumour (except colon and rectal)   14             1.4             226      2.0    16    3.6    188    96.8
   AIDS                                                1              0.1             3        0.03   0     0.0    2      0.03
  Type of admission                                                                                                       
   Elective                                            683            67.9            7799     70.6   379   13.5   5202   9.9
   Acute                                               322            32.0            3221     29.2   60    85.6   572    89.6
   Unknown                                             1              0.1             27       0.2    4     0.9    32     0.5
  Type of surgery                                                                                                         
   Open                                                636            63.2            6685     60.5   224   50.6   2838   48.9
   Laparoscopic                                        257            25.6            3236     29.3   72    16.2   1160   20.0
   Other                                               113            11.2            1126     10.2   147   33.2   1807   31.1
  Cancer stage                                                                                                            
   Localised                                           450            44.7            4291     38.8   179   40.4   2048   35.3
   Regional                                            202            20.1            2928     26.5   113   25.5   2033   35.0
   Metastasised                                        214            21.3            2418     21.9   70    15.8   904    15.6
   Unknown                                             140            13.9            1410     12.8   81    18.3   821    14.1

COPD, chronic obstructive pulmonary disease.

ICU admission, ICU treatments and reoperation within 30 days after surgery {#s3b}
--------------------------------------------------------------------------

Among patients with CRC with COPD, 16.1% (95% CI 14.3% to 18.1%) were admitted to the ICU 1--30 days after surgery, compared with 9.7% (95% CI 9.3% to 10.2%) of patients without COPD ([table 2](#BMJRESP2014000036TB2){ref-type="table"}). In the sensitivity analysis including days 0--30 after surgery, we found an ICU admission rate of 29.0% (95% CI 26.7% to 31.4%) among patients with COPD and 17.6% (95% CI 17.0% to 18.2%) among patients without COPD (e-appendix 2).

###### 

Postoperative treatment within 30 days after all colon and rectal cancer surgery by presence/absence of a previous diagnosis of COPD, Denmark, 2005--2011

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------
                      ICU admission (%)     NIV (%)            Mechanical\        Reopera-tion (%)     Dialysis (%)          Treatment with inotropes/ vasopressors (%)
                                                               Ventilation (%)                                               
  ------------------- --------------------- ------------------ ------------------ -------------------- --------------------- --------------------------------------------
  Colorectal cancer                                                                                                          

   COPD               16.1 (14.3 to 18.1)   3.6 (2.7 to 4.7)   1.9 (1.3 to 2.8)   10.6 (9.0 to 12.3)   10.9 (9.3 to 12.6)    11.8 (10.2 to 13.6)

   No COPD            9.7 (9.3 to 10.2)     1.1 (0.9 to 1.2)   1.1 (1.0 to 1.3)   8.0 (7.6 to 8.4)     5.4 (5.1 to 5.8)      6.2 (5.8 to 6.5)

  Colon cancer                                                                                                               

   COPD               17.0 (14.7 to 19.5)   3.8 (2.7 to 5.1)   2.2 (1.4 to 3.3)   11.3 (9.4 to 13.5)   12.5 (10.5 to 14.7)   12.7 (10.7 to 14.9)

   No COPD            9.7 (9.2 to 10.3)     1.2 (1.0 to 1.4)   1.2 (1.0 to 1.4)   7.8 (7.3 to 8.4)     5.9 (5.5 to 6.4)      6.4 (6.0 to 6.9)

  Rectal cancer                                                                                                              

   COPD               14.2 (11.1 to 17.8)   3.2 (1.7 to 5.2)   1.4 (0.5 to 2.3)   8.8 (6.3 to 11.8)    7.2 (5.0 to 10.0)     9.7 (7.1 to 12.9)

   No COPD            9.6 (9.0 to 10.4)     0.9 (0.6 to 1.1)   1.0 (0.8 to 1.3)   8.3 (7.6 to 9.0)     4.5 (4.0 to 5.1)      5.7 (5.1 to 6.3)
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------

Numbers in parentheses are 95% CI.

COPD, chronic obstructive pulmonary disease; ICU, intensive care unit; NIV, non-invasive ventilation.

Patients with CRC with COPD also received mechanical ventilation treatment more frequently (1.9%; 95% CI 1.3% to 2.8%) than patients without COPD (1.1%; 95% CI 1.0% to 1.3%) and more frequently received treatment with NIV (3.6%; 95% CI 2.7% to 4.7% vs 1.1%; 95% CI 0.9% to 1.2%; [table 2](#BMJRESP2014000036TB2){ref-type="table"}).

More patients with CRC with COPD than those without COPD underwent reoperation (10.6% (95% CI 9.0% to 12.3%) vs 8.0% (95% CI 7.6% to 8.4%), particularly due to wound ruptures and bleeding ([tables 2](#BMJRESP2014000036TB2){ref-type="table"} and [3](#BMJRESP2014000036TB3){ref-type="table"}). Patients with COPD more frequently received inotropes/vasopressors than patients without COPD ([table 2](#BMJRESP2014000036TB2){ref-type="table"}). In addition, ICU admissions, ICU treatments and reoperations were generally more frequent in the acute than in the elective setting, both among patients with CRC with and without COPD (e-appendix 2).

###### 

Postoperative reoperations within 30 days after all colorectal cancer surgery by presence/absence of a previous diagnosis of chronic obstructive pulmonary disease (COPD), Denmark, 2005--2011

         Wound rupture (%)   Superficial/deep infection (%)   Superficial/deep bleeding (%)   Anastomosis leakage (%)   Other reason for reoperation (%)
  ------ ------------------- -------------------------------- ------------------------------- ------------------------- ----------------------------------
  COPD                                                                                                                  
   Yes   4.1 (3.2 to 5.3)    0.9 (0.5 to 1.5)                 2.1 (1.4 to 2.9)                3.5 (2.6 to 4.6)          1.0 (0.5 to 1.6)
   No    2.0 (1.8 to 2.2)    1.3 (1.1 to 1.5)                 0.8 (0.7 to 1.0)                3.1 (2.9 to 3.4)          0.7 (0.6 to 0.9)

Numbers in parentheses are 95% CI.

The results were similar when colon cancer and rectal cancer were considered separately ([table 2](#BMJRESP2014000036TB2){ref-type="table"}).

In an analysis by year of CRC surgery, we found that the frequency of ICU admission declined for CRC surgery overall from 41.6% in 2005 to 25.8% in 2011 (Results in e-appendix 2). Among patients with CRC without COPD, 24% were admitted to the ICU in 2005 and 12.8% were admitted in 2011. Thus, while the frequency of ICU admission declined over time among patients with CRC overall, the frequency continued to be highest among patients with CRC with COPD.

In contrast, we found that the rate of patients treated with mechanical ventilation increased from 1.2% in 2005 to 2% in 2010 among patients with CRC with COPD. In patients with CRC without COPD, the frequency increased from 0.8% to 1.2%. The frequency of reoperation was stable throughout the study period, except for a higher frequency in 2005 (e-appendix 2).

Mortality {#s3c}
---------

Thirty-day mortality after CRC surgery was 13.0% (95% CI 11.4% to 14.9%) among patients with CRC with COPD and 5.3% (95% CI 5% to 5.7%) among patients with CRC without COPD, corresponding to an adjusted HR of 1.7 (95% CI 1.5 to 2.0). Mortality in patients with CRC with COPD started to diverge from that in patients with CRC without COPD approximately 3 days after surgery ([figure 1](#BMJRESP2014000036F1){ref-type="fig"}).

![Kaplan-Meier 30-day survival curves for patients with colorectal cancer with and without chronic obstructive pulmonary disease (COPD).](bmjresp2014000036f01){#BMJRESP2014000036F1}

Thirty-day mortality was 14.8% (95% CI 12.8% to 17.2%) in patients with colon cancer with COPD and 6.2% (95% CI 5.8% to 6.7%) in patients with colon cancer without COPD, corresponding to an adjusted HR of 1.8 (95% CI 1.5% to 2.1%).

Thirty-day mortality was 9.0% (95% CI 6.7% to 12.1%) in patients with rectal cancer with COPD and 3.7% (95% CI 3.3% to 4.2%) in patients with rectal cancer without COPD. The adjusted HR was 1.6 (95% CI 1.1% to 2.2%; [table 4](#BMJRESP2014000036TB4){ref-type="table"}).

###### 

Thirty-day mortality and HRs after colorectal cancer surgery by presence/absence of chronic obstructive pulmonary disease (COPD), Denmark, 2005--2011

            Colorectal cancer   Colon cancer          Rectal cancer                                                                               
  --------- ------------------- --------------------- ------------------ ----- --------------------- ------------------ ----- ------------------- ------------------
  COPD      189                 13.0 (11.4 to 14.9)   1.7 (1.5 to 2.0)   149   14.8 (12.8 to 17.2)   1.8 (1.5 to 2.1)   40    9.0 (6.7 to 12.1)   1.6 (1.1 to 2.2)
  No COPD   899                 5.3 (5.0 to 5.7)      1.00 (ref)         684   6.2 (5.8 to 6.7)      1.00 (ref)         215   3.7 (3.3 to 4.2)    1.00 (ref)

\*Adjusted for age, gender, type of admission, cancer stage, hospital volume, obesity and alcohol-related diseases and Charlson Comorbidity Index score.

Stratified analyses {#s3d}
-------------------

Stratified analyses showed that COPD had a particularly strong impact on 30-day mortality among patients less than 70 years of age (HR=2.0; 95% CI 1.3% to 3.0%), among men (HR=1.9; 95% CI 1.6% to 2.4%), among patients undergoing elective surgery (HR=2.2; 95% CI 1.8% to 2.8%), among patients undergoing surgery in a low volume hospital (HR=2.1; 95% CI 1.4% to 3.0%) and among patients undergoing laparoscopic surgery (HR=2.9; 95% CI 1.8% to 4.7%; [table 5](#BMJRESP2014000036TB5){ref-type="table"}).

###### 

Crude and adjusted HRs for death after colorectal cancer (CRC) surgery, comparing patients with chronic obstructive pulmonary disease (COPD) to those without

                      Colorectal cancer                      
  ------------------- ------------------- ------------------ -----
  *Stratified by*                                            
  Age group (years)                                          
   0--69              2.5 (1.5 to 4.1)    2.0 (1.3 to 3.0)   1.0
   70+                1.9 (1.6 to 2.3)    1.6 (1.4 to 2.0)   1.0
  Gender                                                     
   Male               2.9 (2.4 to 3.6)    1.9 (1.6 to 2.4)   1.0
   Female             2.1 (1.7 to 2.7)    1.5 (1.2 to 1.9)   1.0
  Charlson score                                             
   0                  2.7 (2.2 to 3.4)    2.1 (1.7 to 2.6)   1.0
   1--2               1.7 (1.3 to 2.3)    1.5 (1.1 to 1.9)   1.0
   3+                 1.7 (1.1 to 2.6)    1.5 (1.0 to 2.3)   1.0
  Type of admission                                          
   Elective           3.3 (2.7 to 4.1)    2.2 (1.8 to 2.8)   1.0
   Acute              1.8 (1.4 to 2.2)    1.4 (1.1 to 1.7)   1.0
  Hospital volume                                            
   Low (0--500)       2.8 (2.0 to 4.0)    2.1 (1.4 to 3.0)   1.0
   High (\>500)       2.5 (2.1 to 3.0)    1.7 (1.4 to 2.0)   1.0
  Type of Surgery                                            
   Open               2.8 (2.3 to 3.5)    2.0 (1.6 to 2.4)   1.0
   Laparoscopic       4.4 (2.8 to 7.0)    2.9 (1.8 to 4.7)   1.0
   Other              1.4 (1.0 to 2.0)    1.0 (0.7 to 1.5)   1.0
  CRC stage                                                  
   Localised          2.9 (2.2 to 3.8)    1.9 (1.4 to 2.5)   1.0
   Regional           3.4 (2.3 to 5.0)    2.1 (1.4 to 3.0)   1.0
   Metastasised       2.4 (1.8 to 3.2)    1.7 (1.2 to 2.2)   1.0
   Unknown            1.7 (1.2 to 2.5)    1.4 (0.9 to 2.0)   1.0

Discussion {#s4}
==========

Key messages {#s4a}
------------

-   Surgery in patients with CRC with COPD is more frequently associated with complications leading to ICU admission/treatments, and reoperations, compared to patients with CRC without COPD.

-   COPD is clearly associated with increased mortality, especially in patients with colon cancer.

Other studies {#s4b}
-------------

To the best of our knowledge, this is the first study to focus specifically on the impact of COPD on postoperative mortality and, in particular, intensive care treatment among patients with CRC. Nonetheless, our mortality results are in accord with those of a study by Osler *et al* who investigated hospital differences in mortality after CRC surgery.[@R4] In that study, presence of COPD was associated with a 71% increase in 30-day mortality compared to CRC patients without COPD. Studies investigating the impact of COPD on mortality after other types of surgery have also demonstrated an association.[@R6] [@R22] For example, Ried *et al*[@R7] found that 6.1% of patients with COPD died within 30 days of cardiac surgery, compared to 0.8% of patients without COPD. Moreover, a study by Christensen *et al*[@R6] reported a 30-day mortality of 44% after surgery for peptic ulcer among patients with COPD and 25% among patients without COPD, corresponding to a 50% increased mortality in patients with COPD after adjustment for confounders.

Potential mechanisms {#s4c}
--------------------

Several physiological mechanisms may explain our findings. Previous studies have shown that patients with COPD suffer more often from postoperative respiratory complications, such as pneumonia, than patients without COPD.[@R13] [@R22] This is supported by our findings of an association between COPD and an increased rate of ICU admission, mechanical ventilation and NIV. Nonetheless, the rates of mechanical ventilation and NIV among patients with COPD remained low, suggesting that a substantial proportion of ICU admissions were related to complications not requiring ventilation support. Furthermore, the higher rate of ICU admissions among patients with CRC with COPD, compared to patients without COPD, could possibly be explained by the fact that some hospitals previously routinely admitted patients with COPD to ICU after CRC surgery. Most hospitals have abandoned this practice, as indicated in our study, which found the most pronounced decline in the number of ICU admissions from 2005 to 2011 among patients with COPD.

Patients with severe COPD who experience exacerbations are usually treated with glucocorticoids, which slow wound healing.[@R23] This could account for some postoperative complications experienced by patients with COPD.

Although patients with COPD are less likely to receive laparoscopic surgery, the impact of COPD on mortality was higher in those who had this type of surgery. This increased mortality impact could be due to perioperative hypoventilation when the pressure in the abdomen is increased during laparoscopic surgery, especially since patients with COPD already have decreased lung capacity.

We observed a relatively lower impact of COPD on mortality in acute patients than in elective patients, which may be explained by the higher absolute mortality risk in acute patients even without COPD.

A previous study found that patients with CRC with COPD are diagnosed and treated earlier than patients without COPD, so delay in diagnosis and treatment cannot therefore explain the poor prognosis.[@R24]

Limitations {#s4d}
-----------

In this nationwide population-based study conducted in a homogeneous healthcare system, we had complete DCR data and complete follow-up for death, allowing almost no risk of selection bias.[@R25] Nonetheless, COPD may be under-reported in the DNRP, in which case we have included some true patients with COPD in the comparison cohort. Such misclassification would have caused us to conservatively bias the relative risk estimates. In the Danish study by Osler *et al*, however, where COPD was defined using both hospitalisations and prescriptions, the COPD prevalence was 11.2%, which is in accord with our findings.[@R4] These findings may imply that under-reporting of COPD is not a major problem in our study. Furthermore, the coding of COPD and ICU admissions and treatments in the DNRP has been demonstrated to have a high-positive predictive value.[@R26] [@R27] However, the DNRP does not include detailed clinical data on severity of COPD, and we were therefore unable to evaluate any influence of COPD severity.

We controlled for several important sources of confounding, such as obesity, alcohol-related diseases and other comorbidities. The positive predictive value of the DNRP coding of all diseases included in the CCI is known to be high,[@R28] but the index includes limited information on the severity of comorbidity. Despite this, the CCI performs well in colorectal cancer surgery patients.[@R29] However, we cannot entirely rule out unmeasured confounding from smoking and incomplete measurement of comorbidity including obesity and alcohol-related diseases.

Although it is very likely that deaths occurring 30 days or less after CRC surgery are caused by complications, information on causes of death may have provided further insight into the mechanisms leading to increased mortality among patients with COPD. Unfortunately, we had no information on causes of death.

Finally and as mentioned above, rates of ICU admissions among patients with COPD may reflect clinical practice of routine 'prophylactic' admission rather than ICU admissions as a marker of postoperative complications; however, we addressed this by excluding ICU admission on the day of surgery. By excluding patients admitted to the ICU on the first postoperative day, we may also have excluded some patients with COPD with immediate surgical complications (eg, patients not extubated in the operating room, but transferred to the ICU due to perioperative respiratory complications).Sensitivity analysis aimed to address this issue.

Our findings of a substantial impact of COPD on postoperative morbidity and mortality after CRC surgery underscore the need for close postoperative surveillance of patients with CRC with COPD.

In conclusion, we found an increased rate of ICU admission, mechanical ventilation, NIV and reoperation after CRC surgery in patients with COPD, compared with patients with CRC without COPD. In addition, COPD was associated with increased 30-day mortality after CRC surgery.
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